Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
8 trials
Recent
Start date
Enrollment
INDUSTRY
×
zimberelimab
×
Thoracic
×
Clear all
Filters
3
NCT05633667
2026-03-17
VELOCITY-Lung
Gilead Sciences
Phase 2
Recruiting
270 enrolled
NCT04736173
2026-03-09
ARC-10
Arcus Biosciences, Inc.
Phase 2
Active not recruiting
169 enrolled
NCT05891171
2026-02-27
ARC-25
Arcus Biosciences, Inc.
Phase 1
Active not recruiting
40 enrolled
NCT05502237
2026-01-30
STAR-121
Gilead Sciences
Phase 3
Active not recruiting
1,021 enrolled
NCT05676931
2025-10-02
EDGE-Lung
Gilead Sciences
Phase 2
Active not recruiting
400 enrolled
NCT04772989
2025-08-28
ARC-12
Arcus Biosciences, Inc.
Phase 1
Completed
94 enrolled
NCT04262856
2025-08-26
ARC-7
Arcus Biosciences, Inc.
Phase 2
Completed
151 enrolled
NCT03846310
2024-12-09
ARC-4
Arcus Biosciences, Inc.
Phase 1
Completed
77 enrolled